Model‐based dose finding under model uncertainty using general parametric models
Abstract
The statistical methodology for the design and analysis of clinical Phase II dose‐response studies, with related software implementation, is well developed for the case of a normally distributed, homoscedastic response considered for a single timepoint in parallel group study designs. In practice, however, binary, count, or time‐to‐event endpoints are encountered, typically measured repeatedly over time and sometimes in more complex settings like crossover study designs. In this paper, we develop an overarching methodology to perform efficient multiple comparisons and modeling for dose finding, under uncertainty about the dose‐response shape, using general parametric models. The framework described here is quite broad and can be utilized in situations involving for example generalized nonlinear models, linear and nonlinear mixed effects models, Cox proportional hazards models, with the main restriction being that a univariate dose‐response relationship is modeled, that is, both dose and response correspond to univariate measurements. In addition to the core framework, we also develop a general purpose methodology to fit dose‐response data in a computationally and statistically efficient way. Several examples illustrate the breadth of applicability of the results. For the analyses, we developed the R add‐on package DoseFinding, which provides a convenient interface to the general approach adopted here. Copyright © 2013 John Wiley & Sons, Ltd.
Citing Literature
Number of times cited according to CrossRef: 51
- Yves Dauvilliers, Gary Zammit, Ingo Fietze, David Mayleben, Dalma Seboek Kinter, Scott Pain, Jan Hedner, Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder, Annals of Neurology, 10.1002/ana.25680, 87, 3, (347-356), (2020).
- Antonio Gonçalves, France Mentré, Annabelle Lemenuel-Diot, Jérémie Guedj, Model Averaging in Viral Dynamic Models, The AAPS Journal, 10.1208/s12248-020-0426-7, 22, 2, (2020).
- Rudolf A. Boer, Julio Núñez, Plamen Kozlovski, Yi Wang, Pieter Proot, Deborah Keefe, Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure, British Journal of Clinical Pharmacology, 10.1111/bcp.14248, 86, 7, (1346-1356), (2020).
- Koutaro Yokote, Misako Sano, Isao Tsumiyama, Deborah Keefe, Dose‐dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity, Diabetes, Obesity and Metabolism, 10.1111/dom.14006, 22, 7, (1102-1110), (2020).
- Harold E. Bays, Plamen Kozlovski, Qing Shao, Pieter Proot, Deborah Keefe, Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity, Obesity, 10.1002/oby.22764, 28, 5, (870-881), (2020).
- Jingjing Chen, Tina Liu, Statistical considerations on implementing the MCP-Mod method for binary endpoints in clinical trials, Contemporary Clinical Trials Communications, 10.1016/j.conctc.2020.100641, (100641), (2020).
- Pierre Verweij, Parisa Danaietash, Bruno Flamion, Joël Ménard, Marc Bellet, Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension, Hypertension, 10.1161/HYPERTENSIONAHA.119.14504, (2020).
- Ursula Debarnot, Franck Di Rienzo, Sebastien Daligault, Sophie Schwartz, Motor Imagery Training During Arm Immobilization Prevents Corticomotor Idling: An EEG Resting-State Analysis, Brain Topography, 10.1007/s10548-020-00763-8, (2020).
- Jihane Aouni, Jean Noel Bacro, Gwladys Toulemonde, Pierre Colin, Loic Darchy, Bernard Sebastien, Design optimization for dose-finding trials: a review, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2020.1730874, (1-12), (2020).
- Nigel Stallard, Lisa Hampson, Norbert Benda, Werner Brannath, Thomas Burnett, Tim Friede, Peter K. Kimani, Franz Koenig, Johannes Krisam, Pavel Mozgunov, Martin Posch, James Wason, Gernot Wassmer, John Whitehead, S. Faye Williamson, Sarah Zohar, Thomas Jaki, Efficient adaptive designs for clinical trials of interventions for COVID-19, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1790415, (1-26), (2020).
- Yusuke Yamaguchi, Toshifumi Sugitani, Sample Size Allocation in Multiregional Dose-Finding Study Using MCP-Mod, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1752298, (1-10), (2020).
- Shiyang Ma, Michael P. McDermott, Generalized multiple contrast tests in dose‐response studies, Statistics in Medicine, 10.1002/sim.8444, 39, 6, (757-772), (2019).
- Marius Thomas, Björn Bornkamp, Martin Posch, Franz König, A multiple comparison procedure for dose‐finding trials with subpopulations, Biometrical Journal, 10.1002/bimj.201800111, 62, 1, (53-68), (2019).
- Marcus Maurer, Ana M. Giménez-Arnau, Gordon Sussman, Martin Metz, Diane R. Baker, Andrea Bauer, Jonathan A. Bernstein, Randolf Brehler, Chia-Yu Chu, Wen-Hung Chung, Inna Danilycheva, Clive Grattan, Jacques Hébert, Constance Katelaris, Michael Makris, Raisa Meshkova, Sinisa Savic, Rodney Sinclair, Karl Sitz, Petra Staubach, Bettina Wedi, Jürgen Löffler, Avantika Barve, Kenneth Kobayashi, Eva Hua, Thomas Severin, Reinhold Janocha, Ligelizumab for Chronic Spontaneous Urticaria, New England Journal of Medicine, 10.1056/NEJMoa1900408, 381, 14, (1321-1332), (2019).
- Lieven Nils Kennes, Gisela Volkers, Georg Kralidis, Study design aspects and inter‐subject variability in longitudinal clinical phase II dose‐finding trials, Pharmaceutical Statistics, 10.1002/pst.1921, 18, 2, (248-259), (2019).
- Sanjiv J. Shah, Adriaan A. Voors, John J. V. McMurray, Dalane W. Kitzman, Thomas Viethen, Antonieta Bomfim Wirtz, Erya Huang, Akos Ferenc Pap, Scott D. Solomon, Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction, JAMA, 10.1001/jama.2019.6717, 321, 21, (2101), (2019).
- Francesco De Pretis, Barbara Osimani, New Insights in Computational Methods for Pharmacovigilance: E-Synthesis, a Bayesian Framework for Causal Assessment, International Journal of Environmental Research and Public Health, 10.3390/ijerph16122221, 16, 12, (2221), (2019).
- Gautham K Rao, Rodney A Prell, Steven T Laing, Stefanie C M Burleson, Allen Nguyen, Jacqueline M McBride, Crystal Zhang, Daniel Sheinson, Wendy G Halpern, In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection, Toxicological Sciences, 10.1093/toxsci/kfz053, (2019).
- Florence Loingeville, Thu Thuy Nguyen, Marie-Karelle Riviere, France Mentré, Robust designs in longitudinal studies accounting for parameter and model uncertainties – application to count data, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2019.1607367, (1-15), (2019).
- Qiqi Deng, Xiaofei Bai, Dacheng Liu, Dooti Roy, Zhiliang Ying, Dan‐Yu Lin, Power and sample size for dose‐finding studies with survival endpoints under model uncertainty, Biometrics, 10.1111/biom.12968, 75, 1, (308-314), (2018).
- Saswati Saha, Werner Brannath, Comparison of different approaches for dose response analysis, Biometrical Journal, 10.1002/bimj.201700276, 61, 1, (83-100), (2018).
- A. Lawrence Gould, BMA‐Mod: A Bayesian model averaging strategy for determining dose‐response relationships in the presence of model uncertainty, Biometrical Journal, 10.1002/bimj.201700211, 61, 5, (1141-1159), (2018).
- Anneleen Daemen, Bonnie Liu, Kyung Song, Mandy Kwong, Min Gao, Rebecca Hong, Michelle Nannini, David Peterson, Bianca M. Liederer, Cecile de la Cruz, Dewakar Sangaraju, Allan Jaochico, Xiaofeng Zhao, Wendy Sandoval, Thomas Hunsaker, Ron Firestein, Sheerin Latham, Deepak Sampath, Marie Evangelista, Georgia Hatzivassiliou, Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State, Cell Metabolism, 10.1016/j.cmet.2018.06.003, 28, 3, (383-399.e9), (2018).
- Simon Buatois, Sebastian Ueckert, Nicolas Frey, Sylvie Retout, France Mentré, Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models, The AAPS Journal, 10.1208/s12248-018-0205-x, 20, 3, (2018).
- Cyrielle Dumont, Giulia Lestini, Hervé Le Nagard, France Mentré, Emmanuelle Comets, Thu Thuy Nguyen, for the PFIM group, PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models, Computer Methods and Programs in Biomedicine, 10.1016/j.cmpb.2018.01.008, 156, (217-229), (2018).
- Eric Gibson, Frank Bretz, Michael Looby, Bjoern Bornkamp, Key Aspects of Modern, Quantitative Drug Development, Statistics in Biosciences, 10.1007/s12561-017-9203-2, 10, 2, (283-296), (2018).
- T. Jaki, A. Gordon, P. Forster, L. Bijnens, B. Bornkamp, W. Brannath, R. Fontana, M. Gasparini, L.V. Hampson, T. Jacobs, B. Jones, X. Paoletti, M. Posch, A. Titman, R. Vonk, F. Koenig, A proposal for a new PhD level curriculum on quantitative methods for drug development, Pharmaceutical Statistics, 10.1002/pst.1873, 17, 5, (593-606), (2018).
- Jakob Kotas, Archis Ghate, Bayesian learning of dose–response parameters from a cohort under response-guided dosing, European Journal of Operational Research, 10.1016/j.ejor.2017.07.034, 265, 1, (328-343), (2018).
- Scott R. Montgomery, J. Christoph Katthagen, Jacob D. Mikula, Daniel Cole Marchetti, Dimitri S. Tahal, Grant J. Dornan, Kimi D. Dahl, Alex W. Brady, Travis Lee Turnbull, Peter J. Millett, Anatomic and Biomechanical Comparison of the Classic and Congruent-Arc Techniques of the Latarjet Procedure, The American Journal of Sports Medicine, 10.1177/0363546516685318, 45, 6, (1252-1260), (2017).
- Yaohua Zhang, Qiqi Deng, Susan Wang, Naitee Ting, A Simple and Efficient Statistical Approach for Designing an Early Phase II Clinical Trial: Ordinal Linear Contrast Test, New Advances in Statistics and Data Science, 10.1007/978-3-319-69416-0_11, (179-196), (2017).
- David C. Norris, Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials, F1000Research, 10.12688/f1000research.10624.2, 6, (112), (2017).
- E. Colucci, A. Clark, C.E. Lang, V.M. Pomeroy, A rule-based, dose-finding design for use in stroke rehabilitation research: methodological development, Physiotherapy, 10.1016/j.physio.2016.10.393, 103, 4, (414-422), (2017).
- Yijie Zhou, Su Chen, Danielle Sullivan, Yihan Li, Ying Zhang, Wangang Xie, Hongtao Zhang, Yuanyuan Tang, Li Wang, Alan Hartford, Bo Yang, Dose-ranging design and analysis methods to identify the minimum effective dose (MED), Contemporary Clinical Trials, 10.1016/j.cct.2017.08.005, 63, (59-66), (2017).
- Yasunori Aoki, Daniel Röshammar, Bengt Hamrén, Andrew C. Hooker, Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection, Journal of Pharmacokinetics and Pharmacodynamics, 10.1007/s10928-017-9550-0, 44, 6, (581-597), (2017).
- David C. Norris, Dose Titration Algorithm Tuning (DTAT) should supersede the Maximum Tolerated Dose (MTD) concept in oncology dose-finding trials, F1000Research, 10.12688/f1000research.10624.1, 6, (112), (2017).
- David C. Norris, Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials, F1000Research, 10.12688/f1000research.10624.3, 6, (112), (2017).
- Neal Thomas, Understanding MCP‐MOD dose finding as a method based on linear regression, Statistics in Medicine, 10.1002/sim.7424, 36, 27, (4401-4413), (2017).
- Yuanyuan Tang, Chunyan Cai, Liangrui Sun, Jianghua He, Bayesian penalized log-likelihood ratio approach for dose response clinical trial studies, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1293081, 27, 6, (975-989), (2017).
- Luzia A. Trinca, Steven G. Gilmour, Split-Plot and Multi-Stratum Designs for Statistical Inference, Technometrics, 10.1080/00401706.2017.1316315, 59, 4, (446-457), (2017).
- Georg Gutjahr, Björn Bornkamp, Likelihood ratio tests for a dose‐response effect using multiple nonlinear regression models, Biometrics, 10.1111/biom.12563, 73, 1, (197-205), (2016).
- Neal Thomas, Dooti Roy, Analysis of Clinical Dose–Response in Small-Molecule Drug Development: 2009–2014, Statistics in Biopharmaceutical Research, 10.1080/19466315.2016.1256229, 9, 2, (137-146), (2016).
- T Berge, I S Leikfoss, I S Brorson, S D Bos, C M Page, M W Gustavsen, A Bjølgerud, T Holmøy, E G Celius, J Damoiseaux, J Smolders, H F Harbo, A Spurkland, The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells, Genes & Immunity, 10.1038/gene.2015.61, 17, 2, (118-127), (2016).
- Jonathan L. Kane, Sarah A. Krueger, Alaa Hanna, Thomas R. Raffel, George D. Wilson, Gerard J. Madlambayan, Brian Marples, Effect of Irradiation on Tumor Microenvironment and Bone Marrow Cell Migration in a Preclinical Tumor Model, International Journal of Radiation Oncology*Biology*Physics, 10.1016/j.ijrobp.2016.04.028, 96, 1, (170-178), (2016).
- B. Bieth, B. Bornkamp, C. Toutain, R. Garcia, J. P. Mochel, Multiple comparison procedure and modeling: a versatile tool for evaluating dose–response relationships in veterinary pharmacology – a case study with furosemide, Journal of Veterinary Pharmacology and Therapeutics, 10.1111/jvp.12313, 39, 6, (539-546), (2016).
- Kirsten Schorning, Björn Bornkamp, Frank Bretz, Holger Dette, Model selection versus model averaging in dose finding studies, Statistics in Medicine, 10.1002/sim.6991, 35, 22, (4021-4040), (2016).
- Markus Hinder, Alexander Schuhmacher, The Evolution of Clinical Development: From Technical Success to Clinical Value Creation, Value Creation in the Pharmaceutical Industry, 10.1002/9783527693405, (202-223), (2016).
- Holger Dette, Stefanie Titoff, Stanislav Volgushev, Frank Bretz, Dose response signal detection under model uncertainty, Biometrics, 10.1111/biom.12357, 71, 4, (996-1008), (2015).
- Georg Ferber, Ekkehard Glimm, Translational Science Biostatistics, Principles of Translational Science in Medicine, 10.1016/B978-0-12-800687-0.00029-3, (267-280), (2015).
- Francois Mercier, Bjoern Bornkamp, David Ohlssen, Erik Wallstroem, Characterization of dose‐response for count data using a generalized MCP‐Mod approach in an adaptive dose‐ranging trial, Pharmaceutical Statistics, 10.1002/pst.1693, 14, 4, (359-367), (2015).
- Björn Bornkamp, Viewpoint: model selection uncertainty, pre‐specification, and model averaging, Pharmaceutical Statistics, 10.1002/pst.1671, 14, 2, (79-81), (2015).
- Christian Ritz, Florent Baty, Jens C. Streibig, Daniel Gerhard, Dose-Response Analysis Using R, PLOS ONE, 10.1371/journal.pone.0146021, 10, 12, (e0146021), (2015).




